Type of leukemia-Acute Myeloid Leukemia (AML) Posts on Medivizor
Navigation Menu

Type of leukemia-Acute Myeloid Leukemia (AML) Posts on Medivizor

Is venetoclax with decitabine or azacitidine effective in treating elderly patients with acute myeloid leukemia?

Posted by on Feb 16, 2019 in Leukemia | 0 comments

In a nutshell This study examined If venetoclax (Venclexta) with decitabine (Dacogen) or azacitidine (Vidaza) is effective in treating elderly patients with acute myeloid leukemia (AML).  This study concluded that venetoclax with decitabine or azacitidine could be an effective treatment in these patients.  Some background Acute...

Read More

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants

Posted by on Dec 15, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to identify risk factors of tiredness in children treated for leukemia and lymphoma or who received a stem cell transplant. Researchers found that older age and active treatment were risk factors for developing severe tiredness in these patients. Some background Cancer treatment leads to severe tiredness (fatigue) over...

Read More

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants.

Posted by on Dec 15, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to identify risk factors of tiredness in children treated for leukemia and lymphoma or who received a stem cell transplant. Researchers found that older age and active treatment were risk factors for developing severe tiredness in these patients. Some background Cancer treatment leads to severe tiredness (fatigue) over...

Read More

Survival from transplant of donor bone marrow versus donor blood sample in leukemia treatment

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of donor peripheral blood (PB) with bone marrow (BM) transplant in the treatment of leukemia. Researchers found that bone marrow transplants are safer and more effective in the treatment of leukemia. Some background Leukemia is a cancer of the bone marrow. It may lead to abnormal immune...

Read More

Do ACE inhibitors help with anthracycline-induced cardiotoxicity in leukemia and lymphoma?

Posted by on Dec 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate if enalapril influences anthracycline-induced cardiotoxicity in children with leukemia and lymphoma. This study concluded that enalapril has a role in reducing anthracycline-induced cardiotoxicity in these patients. Some background Anthracyclines are a class of chemotherapy drugs that can be used for...

Read More

Adding Lomustine to chemotherapy for acute myeloid leukemia for elderly patients

Posted by on Nov 26, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of adding lomustine (Gleostine) to chemotherapy in the treatment of acute myeloid leukemia in patients aged over 60. Researchers found that this treatment improved outcomes for elderly patients with AML. Some background Acute myeloid leukemia (AML) is a cancer of the bone marrow....

Read More

Arsenic trioxide and retinoic acid in the treatment of acute promyelocytic leukemia

Posted by on Oct 14, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the safety and effectiveness of arsenic trioxide (Trisenox; ATO) and all-trans-retinoic acid (Vesanoid; ATRA) in the treatment of relapsed (cancer return) acute promyelocytic leukemia (APL). Researchers found that long-term ATO-ATRA treatment may improve the outcomes of these patients. Some background Acute...

Read More

Congestive heart failure in children with acute leukemia

Posted by on Sep 15, 2018 in Leukemia | 0 comments

In a nutshell This study identified the risks and incidence of congestive heart failure in children with acute leukemia (ALL or AML). The study found that risks of heart failure with ALL or AML included female gender and diagnosis at a younger age. Some background Congestive heart failure (CHF) is a condition in which the heart is unable to pump blood...

Read More

Is a low-intensity chemotherapy treatment plan safe and effective for elderly patients with Acute Myeloid Leukemia?

Posted by on Sep 6, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to create a safe and effective low-intensity chemotherapy treatment plan for elderly patients with AML . This is an ongoing clinical trial and so far the authors have found the therapy has been safe and effective. Some background Outcomes for elderly patients with AML in the past have not been good due to the high...

Read More